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You request a ruling on behalf of *************** (hereinafter, “the Company”), a Delaware corporation
doing business in Massachusetts.  You raise several issues relative to whether the Company
qualifies as a foreign research and development corporation within the meaning of General Laws
chapter 63, section 42B. Specifically, you ask whether (1) the Company’s principal activity in
Massachusetts is research and development; (2) the Company derives more than two-thirds of its
receipts assignable to Massachusetts from research and development; and (3) the Company derives
more than one-third of its receipts assignable to Massachusetts from research and development of
tangible personal property capable of being manufactured in Massachusetts.
STATEMENT OF FACTS
The Company is a biopharmaceutical company with three areas of focus: technology, therapeutics,
and sales of pharmaceutical products.  Through its technological focus, Company identifies and
develops drug and diagnostic candidates for clinical development and brings new medicines to the
market.  The therapeutic focus entails efforts to discover disease-related genes, validating drug
targets and drug leads, and developing and commercializing new drugs to treat major human
illnesses. The first two focuses require extensive research and development (“R&D”) activities.  The
purpose of performing such R&D activities is to ultimately produce pharmaceuticals - the Company's
third focus - that it can manufacture and sell; such R&D activity occurs primarily in Massachusetts. 
The Company also earns receipts for performing R&D activities for unrelated third parties.
The Company’s research and development facilities are located in Massachusetts and California; its
manufacturing operations are located in California.  The Company currently has 2,314 employees, of
which 1,990 are currently based in Massachusetts.  Sixty-nine percent (1,383) of those employees
based in Massachusetts primarily perform R&D activities.  Approximately 130 employees in
California primarily perform R&D activities.  Although the Company’s principal sales offices are
located outside of the Commonwealth, some sales activity does occur in Massachusetts.  For the
year 2002, the Company expects to have receipts of approximately $350 million, $150 million (43%)
of which will be from sales of pharmaceuticals and $200 million (57%) of which will be from
performing R&D services.  All of the Company’s 2002 revenue generating R&D services were
performed in Massachusetts and were performed for the purpose of bringing pharmaceuticals to
market.   None of the Company’s 2002 pharmaceutical sales were of products manufactured in
Massachusetts.  None of the Company’s 2002 pharmaceutical sales were made to customers in
Massachusetts.  The Company had a small percentage of receipts from other sources, none of
which were related to business activity carried on in Massachusetts.
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DISCUSSION
A.  Relevant statute and regulation
Chapter 63, section 42B is the relevant statutory provision governing foreign research and
development corporation.  It states as follows:
Every corporation, association or organization established, organized or chartered under laws
other than those of the commonwealth, which has a usual place of business in the
commonwealth and is engaged in manufacturing therein, or engaged therein in research or
development of products capable of being manufactured therein, shall, for the purposes of this
chapter be deemed to be a . . . a foreign research and development corporation.
A “foreign research and development corporation” is further defined in G.L. c. 63, § 42B as “. . . one
whose principal activity herein is research and development and (emphasis added) which derives
more than two thirds of its receipts assignable to the commonwealth from such activity and derives
more than one third of its receipts assignable to the commonwealth from the research and
development of tangible personal property capable of being manufactured in this commonwealth”.
To summarize, and as re-stated in the Department of Revenue’s Research and Development
regulation, 830 CMR 64H.6.4, Company must meet three requirements to qualify as a foreign
research and development corporation:
1)  it must have a usual place of business in Massachusetts;
2)  its principal activity in Massachusetts must be research and development; and
3)  it must (i) derive more than two thirds of its receipts assignable to Massachusetts from
research and development, and (ii) must derive more than one third of its receipts assignable to
Massachusetts from the research and development of tangible personal property capable of
being manufactured in Massachusetts.
See G.L. c. 63, § 42B; 830 CMR 64H.6.4(4)(c).
B.  Company’s qualification as a “foreign research and development corporation”
Based on the facts as you state them, Company clearly meets the first two requirements.  With
respect to the first requirement, the Company has a usual place of business in Massachusetts since
its research and development facilities are located in Massachusetts. 
As to the second requirement, Company’s principal activity in Massachusetts is research and
development.  In 830 CMR 64H.6.4(2), the Department defined the phrase “research and
development” as “experimental or laboratory activity that has as its ultimate goal the development of
new products, the improvement of existing products, the development of new uses for existing
products, or the development or improvement of methods for producing products.”  Company’s
activities in Massachusetts, through its focus on technology and therapeutics, are either to bring new
medicines to market or to develop new products and services for clinicians and researchers to use
in treating patients.  Such activities clearly fall within the definition of research and development.
Having a majority of Massachusetts based employees engaged in R&D activity, though not essential,
demonstrates that a taxpayer’s principal activity in Massachusetts is R&D.   In this case, Company
has represented that 69% of its Massachusetts-base employees primarily perform R&D activities. 
Company has demonstrated that it meets the second requirement.
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With respect to the third requirement, two percentage tests must be met.  First, Company must
derive more than two-thirds of its receipts assignable to Massachusetts from research and
development. As represented by the Company, 100% of its Massachusetts assignable receipts in
2002 are from R&D.  The ratio (Massachusetts assignable R&D receipts over total Massachusetts
receipts) for the third requirement would, therefore, be $200 million over $200 million.  We find that
the two-thirds test is met.
The second percentage test requires that more than one-third of these receipts must be from the
research and development of “tangible personal property capable of being manufactured in this
Commonwealth”.  Similarly, neither G.L. c. 63, § 42B, nor the Research and Development regulation
defines the phrase “tangible personal property capable of being manufactured in this
Commonwealth.”  However, in interpreting the meaning of other phrases (“manufacturing
corporation”) in G.L. c. 63, § 42B, the Massachusetts Appellate Tax Board (ATB) has noted that
“[o]ur courts have presumed that the Legislature intended to adopt the common meaning of the word
with some considerations to the historical origins of the enactment.”  Electronics Corp. of America v.
Commissioner of Revenue (1995) A.T.B. No. 153028, citing First Data Corp. v. State Tax
Commission, 371 Mass. 444, 447 (1976).  In interpreting the phrase “engaged in manufacturing”
which also appears in G.L. c. 63, § 42B, the ATB noted that the Massachusetts Supreme Judicial
Court has stated that “[f]or purposes of applying the subject statute, [this phrase] is not to be given a
restrictive meaning.”  Id., citing Joseph T. Rossi Corp. v. State Tax Commission, 369 Mass. 1978
(1975).
The SJC has long been mindful that “[t]he statutes granting exemption must be fairly construed and
reasonably applied in order to effectuate the legislative intent and purpose to promote the general
welfare of the Commonwealth by inducing new industries to locate here and to foster the expansion
and development of our own industries, so that the production of goods can be stimulated, steady
employment afforded to our citizens, and a large measure of prosperity sustained.”  Id. at 8, citing
Assessors of Boston v. Commissioner of Corps. & Taxation, 323 Mass. 730, 741 (1949) (refusing to
restrict definition of manufacturing corporations to those whose principal business is manufacturing).
Although none of the cases cited above construed the phrase “tangible personal property capable of
being manufactured in this Commonwealth,” we think the same interpretive principles apply to this
phrase as well.  In construing G.L. c. 63 in its entirety, the SJC has said “[t]he legislative intent is to
be ascertained from the statute as a whole giving to every section, clause and word such force and
effect as are reasonably practical to the end that, as far as possible, the statute will constitute a
consistent and harmonious whole, capable of producing a rational result consonant with common
sense and sound judgment.  Haines v. Town Manager of Mansfield, 320 Mass. 140, 142. 
Commissioner of Corps & Taxn. v. Springfield, 321 Mass. 31, 36 (1947).
Thus, we begin with the notion that this phrase, like those § 42B phrases already construed by the
courts, need not be restrictively interpreted.  The fact that the Company’s products are currently
manufactured in California and that the R&D it performs for third parties may not actually result in
property being manufactured in Massachusetts does not disqualify it from meeting the second test.
As represented by the Company, 100% of its Massachusetts receipts in 2002 will be from R&D
business activity.  Company has further represented that such R&D activity is for the purpose of
bringing pharmaceuticals to market.  Thus, we find that the Company meets the second percentage
test requiring that one-third of its receipts assignable to Massachusetts be from research and
development of tangible personal property capable of being manufactured here.
CONCLUSION
As to whether the Company will qualify in 2002 as a Massachusetts Research and Development
Corporation pursuant to G.L. chapter 63, § 42B, we conclude, based on the facts presented, that the
company will so qualify.
Very truly yours,
/s/Alan LeBovidge
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